×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
LON:GPL

Graft Polymer Share Forecast, Price & News

GBX 16.10
0.00 (0.00%)
(As of 07/4/2022 12:00 AM ET)
Add
Compare
Today's Range
16
16.10
50-Day Range
N/A
52-Week Range
14.70
22.46
Volume
N/A
Average Volume
N/A
Market Capitalization
£16.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Graft Polymer MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
£7.40 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.69 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive GPL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Graft Polymer and its competitors with MarketBeat's FREE daily newsletter.

About Graft Polymer

Graft Polymer (UK) Plc engages in the research, development, and commercialization of polymer modification technologies and techniques in the United Kingdom and Europe. The company offers GRAFTABOND, a line of graft/block copolymers for combining various polymers with fiberglass, carbon fiber, mineral and natural fillers, and mixed polymer waste; GRAFTALEN, a line of reactive solid super-concentrates for polyolefin rheology modification, e-modulus enhancers, PET/PBT chain extenders, and AOX masterbatch; GRAFTAPOR, a line of porous polymer-carriers for use in liquid chemicals; and GRAFTAMID, a line of high-temperature elastomers based on nanostructured polyolefin-polyamide alloys for use in high-tech hardening modifiers in polyamide compounds, as well as use as an independent compound in hot melt adhesives. It also provides GRAFTAKIT, a reactive liquid or solid super-concentrates on polymeric porous media for carrying out reaction extrusion and modification of compounds; GRAFTALLOY, a line of polymer-polymer nano-alloys to increase abrasion and temperature resistance, and impact strength, as well as reduce friction coefficient; GRAFTASYNT, a line of synthetic products comprising halogen-free flame retardants; and GRAFTAMER, a thermo-reversible crosslinking, self-hardening, and self-healing smart polymer with shape memory, etc. The company was founded in 2001 and is based in London, the United Kingdom.

GPL Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Specialty Industrial Machinery
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£375,429.00
Book Value
GBX 1.20 per share

Miscellaneous

Free Float
N/A
Market Cap
£16.76 million
Optionable
Optionable
Beta
N/A














Graft Polymer Frequently Asked Questions

Should I buy or sell Graft Polymer stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Graft Polymer in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Graft Polymer stock.
View analyst ratings for Graft Polymer
or view top-rated stocks.

How has Graft Polymer's stock performed in 2022?

Graft Polymer's stock was trading at GBX 16 at the beginning of 2022. Since then, GPL shares have increased by 0.6% and is now trading at GBX 16.10.
View the best growth stocks for 2022 here
.

Who are Graft Polymer's key executives?

Graft Polymer's management team includes the following people:
  • Mr. Victor Bolduev, Founder, CEO, CTO & Director (Age 65, Pay $178.04k)
  • Ms. Yifat Steuer, CFO & Director (Age 52, Pay $147.04k)
  • Mr. Pavel Kobzev, Chief Marketing Officer & Director (Age 40, Pay $97.04k)
  • Mr. Anthony Neville Chisholm Eastman BCom, BPHE, CA, Company Sec. (Age 48, Pay $36k)

What is Graft Polymer's stock symbol?

Graft Polymer trades on the London Stock Exchange (LON) under the ticker symbol "GPL."

How do I buy shares of Graft Polymer?

Shares of GPL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Graft Polymer's stock price today?

One share of GPL stock can currently be purchased for approximately GBX 16.10.

How much money does Graft Polymer make?

Graft Polymer (LON:GPL) has a market capitalization of £16.76 million and generates £375,429.00 in revenue each year.

How can I contact Graft Polymer?

The official website for Graft Polymer is www.graftpolymer.com. The company can be reached via phone at 44 20 4524 9900.

This page (LON:GPL) was last updated on 7/4/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.